Healthium Medtech IPO analysis @ Chanakyanipothi.com , India`s Oldest & most Trusted Investment Blog.Operational since 8th December 1999, We are the Only Investment Platform in India, which has successfully completed 21 Years

Healthium Medtech Grey Market News Today #
On
Grey Market Premium Rs. –
Application Rates :Rs. –
Subject to Rates : Rs. –

Healthium Medtech Company Details
Healthium Medtech is a global medtech company focused on products used in surgical, post-surgical and chronic care. Its vision is to deliver access to precision medtech products to every patient globally.
The company operates across three key markets, namely, India, UK and rest of the world and four focus areas, namely, advanced surgery, urology, arthroscopy and wound care. One in five surgeries conducted globally uses a Healthium product as of March 31, 2021
Further, as of Fiscal 2021, it is :
• the largest independent medical device company and second-largest company overall, in the surgical consumables market in India with a 7.91% share based on value;
• the largest non-captive surgical needles manufacturer, with a 22.30% share in overall volume sales globally, and 45.41% share of the non-captive market; and
• one of the largest independent medical device companies and the third-largest company overall in the urology collection devices market in the UK, with a 13.96% market share.

Healthium Medtech has gained market share across its markets and focus areas between Fiscals 2019 and 2021, while imp roving profitability over this period. . It has a comprehensive product platform in its focus areas with over 52,000 SKUs addressing the varied needs of its customers and patients. It competes primarily against large multinational corporations and various local players in each of its key markets and focus areas. The demand for its products is based on the volume of inpatient treatment and surgical procedures. The global market for products in its focus areas is expected to grow at a CAGR of 4.99% between 2021 and 2025 and estimated to be USD 28.75 billion in 2025
for more information, click : www.healthiummedtech.com

The Promoters of Healthium Medtech
Quinag Acquisition (FDI) Ltd

Healthium Medtech IPO Main Objects
The Offer comprises of the Fresh Issue and an Offer for Sale. The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
I. Repayment and/or pre-payment, in full or part, of certain borrowings availed by the Company;
II. Investment into its Subsidiaries, Sironix Medical Technologies B.V. (“Sironix”), Clinisupplies Limited (“Clinisupplies”) and Quality Needles Private Limited (“Quality Needles”);
III.Acquisitions and other strategic initiatives

Healthium Medtech IPO Details
IPO opens on ? Dec, 2021
IPO closes on ? Dec,2021
Issue Type: Book Built Issue IPO
Issue : up to ? Shares /Rs ? Crore
* Fresh Issue of ? Sh/ Rs. 390 Cr
* Offer for Sale Up to 39,100,000 Sh/ Rs. ? Cr

Face Value per share : Rs. 1

Healthium Medtech IPO Price Band Per Equity Share: Rs. (?)
Healthium Medtech IPO Retail Lot Size (?) Shares
Healthium Medtech Listing will at BSE,NSE

Shares offered to
QIB (?%) ?Shares = Rs (?) Cr
NII (?%) ?Shares = Rs (?) Crs
RII (?%) ? Shares = Rs (?) Crs
Lot size: (?) Shares = (?) Forms
Min Retail Application : (?) Sh , Rs. (?)
Max Retail Application : (?) Sh, Rs (?)

Healthium Medtech IPO Tentative timeTable
Healthium Medtech IPO Allotment on ? Dec 2021
Unblocking of ASBA ? Dec 2021
Credit to Demat Accounts ? Dec 2021
Data Patterns Listing on ? Dec 2021

Healthium Medtech IPO Financial Analytical Ratios
Earnings per Share 2019-20 Rs 3.98
Earnings per Share 2020-21,Rs 9.23
Earnings per Share 2021-22 6M Rs ?
Book Value of the Share as on 31.3.2021 Rs 10.584
Return on Net Worth: 19-20 4.00 %
Return on Net Worth: 20-21: 8.70 %
Return on Net Worth: 20-21 6M:( N.A.) %
Upper Price Band/last EPS:
Upper offer price/Book Value Ratio:
Equity Shares prior to the IPO : 97,761,124 Shares

Healthium Medtech IPO Peer Comparison:
There are no listed companies in India whose business portfolio is comparable with that of its business and comparable to its scale of operations.

Healthium Medtech IPO Lead Managers
ICICI Securities ,CLSA india, Credit Suisse Securities (India), Nomura Financial Advisory
Registrar to Healthium Medtech IPO
Kfin Technologies India pvt ltd

Registered Office of Healthium Medtech
472/D, 4th Phase, 13th Cross, Peenya Industrial Area, Bengaluru 560058, Karnataka, India
Company Secretary & Compliance Officer :

#This is only coverage of News related to Grey Market . We donot deal in Grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.